Prevalence of human papillomavirus among females older than recommended age for vaccination by birth cohort, United States 2003‒2016
The Journal of Infectious Diseases Jun 29, 2021
Vahle K, Gargano JW, Lewis RM, et al. - Researchers evaluated overall data, as well as, 10-year birth cohort-specific cervicovaginal HPV prevalence estimates (any, high-risk [HR], and non-HR) by 3-year age group among 27-59 year-old females born between 1950-1979, by utilizing data from 2003-2016 National Health and Nutrition Examination Surveys. Prevalence ratios from log-binomial models were used to compute average percent changes in HPV prevalence by 3-year age. Findings revealed a reduction in the prevalence of any HPV, from 49.9% in 27-29 year-olds to 33.8% in 57–59 year-olds, as well as in the prevalence of HR-HPV and non-HR-HPV. It was concluded that birth cohort differences alone can not explain reductions in HPV prevalence with age in these cross-sectional surveys, because links were observed across all birth cohorts. These observations are consistent with biological and behavioral explanations.
-
Exclusive Write-ups & Webinars by KOLs
-
Daily Quiz by specialty
-
Paid Market Research Surveys
-
Case discussions, News & Journals' summaries